Product Information
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET is a generic product labeled by PAI Holdings LLC, priced at $0.6695 per EA under NDC 00121203630. Its NADAC has been published 121 times since Mar 6, 2024.
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET
buprenorphine hydrochloride and naloxone hydrochlorideStrength
8; 2 mg/1; mg/1
Manufacturer
PAI Holdings LLCNDC
00121203630
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204431On Market Since
9/5/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has been published 121 times since Mar 6, 2024, and over the history we have for it it has declined 33.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6695 per EA |
|---|---|
| All-time high | $1.0433 (Apr 10, 2024) |
| All-time low | $0.6450 (Nov 20, 2024) |
| 52-week high | $0.7397 |
| 52-week low | $0.6616 |
| Median price | $0.7279 |
| Average price | $0.7565 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 121 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the buprenorphine hydrochloride and naloxone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, manufactured by PAI Holdings LLC, is $0.6695 per EA (NDC 00121203630), effective Jun 24, 2026.
How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has declined 33.4%. It has been tracked across 121 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
Since Mar 6, 2024, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has ranged from a low of $0.6450 (Nov 20, 2024) to a high of $1.0433 (Apr 10, 2024), with a median of $0.7279 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, so no direct lower-cost alternative is listed.
Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET (NDC 00121203630) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification